“Rise in incidence & prevalence rate of lung cancer & successful clinical trials of lung cancer drugs are driving the market”
Indore, Nov 2016: Orion Market Research (OMR), recently published a market research report on Global Lung Cancer Therapeutic Market. According to OMR analysis, the Global Lung Cancer Therapeutic Market is expected to grow with a6 CAGR of 13.2 % during 2016-2021. The Global Lung Cancer Therapeutic Market is segmented on the basis of drugs and Geography. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, patent analysis, pipeline analysis, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Full report of Global Lung Cancer Therapeutic Market is available at http://www.omrglobal.com/industry-reports/lung-cancer-therapeutic
“The Global Lung Cancer Therapeutic Market is driven by various pivotal factors which includes rising incidence and prevalence rate of Cancer, successful clinical trials and FDA clearances to critical lung cancer drugs and surgeries. Other key factors such as government investments, grants and private investment are also boosting the market growth. Significant R&D in lung cancer drugs and adoption of personalized medicines are creating huge scope for the market. There is significant growth in the pharmaceutical market of lung cancer drugs due to the huge adoption of lung cancer drugs across the globe.
Global Lung Cancer Therapeutic Market is expected to perform significantly in North America followed by Europe due to a high prevalence rate of lung cancer market. APAC region is predicted to contribute at a modest rate due to the considerable adoption of personalized drugs and improved healthcare spending. The high cost of CNS biomarkers and stringent reimbursement policies are still a concern for the market. However, Global Lung Cancer Therapeutic Market is expected to overcome these challenges through technological advancement and innovation.
Global Lung Cancer Therapeutic Market by region is segmented on the basis of regions which includes North America, Europe, APAC and RoW. North America dominates the global lung cancer therapeutic market due to the huge adoption of global lung cancer therapeutics and huge healthcare spending followed by Europe. The key players of Global Lung Cancer Therapeutic Market includes Boehringer Ingelheim, Eli Lilly, F. Hoffmann-La Roche GlaxoSmithKline, Merck Serono, Novartis and so on.
For Related Reports visit: http://www.omrglobal.com/reports-category/pharmaceuticals/
The report covers:
• Comprehensive research methodology of Lung Cancer Therapeutic market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global Lung Cancer Therapeutic market
• Insights about market determinants which are stimulating the global Lung Cancer Therapeutic market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players
About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.